Press release
Implantable Cardioverter-Defibrillators (ICD) Market Overview Emerging Trends and Competitive Landscape 2020-2025| ZOLL, Boston, BIOTRONIK, Medtronic, St. Jude Medical, Koninklijke Philips
Implantable Cardioverter-Defibrillators (ICD)
Overview of Global Implantable Cardioverter-Defibrillators (ICD) Market:
An implantable cardioverter-defibrillator or automated implantable cardioverter defibrillator is a device implantable inside the body, able to perform cardioversion, defibrillation, and pacing of the heart. The device is therefore capable of correcting most life-threatening cardiac arrhythmias. The ICD is the first-line treatment and prophylactic therapy for patients at risk for sudden cardiac death due to ventricular fibrillation and ventricular tachycardia. Current devices can be programmed to detect abnormal heart rhythms and deliver therapy via programmable antitachycardia pacing in addition to low-energy and high-energy shocks. "AICD" was trademarked by the Boston Scientific corporation, so the more generic "ICD" is preferred terminology.
The report contains a complete product overview and its scope in the market to define the key terms and provide the clients a holistic idea of the market and its tendency. It comprehensively evaluates the global Implantable Cardioverter-Defibrillators (ICD) market with different perspectives for the purpose of providing a detailed, informative, and accurate analysis of regional growth, competition, market segmentation, and other important aspects.
Available Exclusive Sample Copy of this Report @ https://www.businessindustryreports.com/sample-request/235618 .
Growth in the historic period resulted from economic growth in emerging markets, the rise in awareness of the benefits and developed nations towards Implantable Cardioverter-Defibrillators (ICD) costs and an increase in the number of device implantable inside the body, able to perform cardioversion, defibrillation, and pacing of the heart.
Product Type Segmentation:
The Implantable Cardioverter-Defibrillators (ICD) market have different product type such as Subcutaneous Implantable Cardioverter Defibrillators (S-ICDS), Transvenous Implantable Cardioverter-Defibrillator (T-ICDs) and Cardiac Resynchronization Therapy Defibrillator (CRT-D). Implantable Cardioverter-Defibrillators (ICD) market product type gives device implantable inside the body, able to perform cardioversion, defibrillation, and pacing of the heart.
Industry Segmentation:
Increasing instances across various sectors such as ASCs, Hospital and Clinic are raising the need of healthcare institutes, thereby raising the demand for Implantable Cardioverter-Defibrillators (ICD) market. This help in the profitable growth of the Global Implantable Cardioverter-Defibrillators (ICD) market in upcoming year.
Segmentation by Regions:
The Implantable Cardioverter-Defibrillators (ICD) market in North America has created device implantable inside the body, able to perform cardioversion, defibrillation, and pacing of the heart to help patient in the world. It was followed by Western Europe, China, Japan, Southeast Asia, India and Central & South America regions. Asia Pacific is expected to record higher growth rate in Implantable Cardioverter-Defibrillators (ICD) Market during the forecast year.
Purchase this report online with 90 Pages, List of Tables & Figures and in-depth Table of Contents on “Global Implantable Cardioverter-Defibrillators (ICD) Market Report 2020” @ https://www.businessindustryreports.com/buy-now/235618/single .
Top Leading Key Manufacturers are: ZOLL Medical Corporation (US), Boston Scientific Corporation (US), BIOTRONIK SE & Co. KG (Germany), Medtronic PLC (Ireland), St. Jude Medical Inc. (US), Koninklijke Philips N.V. (Netherlands), Medtronic Plc, PHILIPS HEALTHCARE, Sorin Group, Nihon Kohden Corporation. New product launches and continuous technological innovations are the key strategies adopted by the major players.
Top Industry News:
Boston Scientific Receives FDA 510(k) Clearance for the LUX-Dx™ Insertable Cardiac Monitor System on 29 June, 2020 -- First ICM device with remote programming paired with dual-stage arrhythmia detection algorithm
Boston Scientific has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the LUX-Dx Insertable Cardiac Monitor (ICM) System, a new, long-term diagnostic device implanted in patients to detect arrhythmias associated with conditions such as atrial fibrillation (AF), cryptogenic stroke and syncope.
The new LUX-Dx ICM System is designed with a dual-stage algorithm that detects and then verifies potential arrhythmias before an alert is sent to clinicians, thereby providing actionable data for clinical decision-making. Further, the remote programming capabilities of the device via the LATITUDE Clarity Data Management System website allow physicians and care teams to adjust event detection settings without requiring an in-person patient appointment, a feature unavailable on any other ICM currently on the market.
"For physicians, receiving accurate monitoring data and having remote access to programming provides the opportunity to operate with more efficiency and confidence," said Kenneth Stein, M.D., senior vice president and chief medical officer, Rhythm Management and Global Health Policy, Boston Scientific. "The LUX-Dx ICM System is designed to provide physicians the ability to accelerate critical clinical decisions and allow them to spend more time focusing on patient outcomes by reviewing monitoring data and catching false positive detections without compromising sensitivity."
The dual-stage algorithm within the LUX-Dx ICM System can be programmed to identify AF, atrial flutter, rhythm pause, bradycardia and tachycardia episodes and allows the device to detect arrhythmias each time established thresholds or parameters are exceeded. An additional level of verification filters is then applied, which was developed to catch false positive detections before an alert is sent. Additionally, after implant, patients are provided with a mobile device preloaded with the MyLUX app which connects via Bluetooth to their ICM device. The app transmits device data daily, or as needed, to the LATITUDE Clarity Data Management System giving physicians and care teams timely access to vital information.
Grab Your Report at an Impressive Discount @ https://www.businessindustryreports.com/check-discount/235618 .
Major Points in Table of Contents:
1 Implantable Cardioverter-Defibrillators (ICD) Product Definition
2 Global Implantable Cardioverter-Defibrillators (ICD) Market Manufacturer Share and Market Overview
2.1 Global Manufacturer Implantable Cardioverter-Defibrillators (ICD) Shipments
2.2 Global Manufacturer Implantable Cardioverter-Defibrillators (ICD) Business Revenue
2.3 Global Implantable Cardioverter-Defibrillators (ICD) Market Overview
3 Manufacturer Implantable Cardioverter-Defibrillators (ICD) Business Introduction
3.1 ZOLL Medical Corporation (US) Implantable Cardioverter-Defibrillators (ICD) Business Introduction
3.1.1 ZOLL Medical Corporation (US) Implantable Cardioverter-Defibrillators (ICD) Shipments, Price, Revenue and Gross profit 2014-2019
3.1.2 ZOLL Medical Corporation (US) Implantable Cardioverter-Defibrillators (ICD) Business Distribution by Region
3.1.3 ZOLL Medical Corporation (US) Interview Record
3.1.4 ZOLL Medical Corporation (US) Implantable Cardioverter-Defibrillators (ICD) Business Profile
3.1.5 ZOLL Medical Corporation (US) Implantable Cardioverter-Defibrillators (ICD) Product Specification
3.2 Boston Scientific Corporation (US) Implantable Cardioverter-Defibrillators (ICD) Business Introduction
3.2.1 Boston Scientific Corporation (US) Implantable Cardioverter-Defibrillators (ICD) Shipments, Price, Revenue and Gross profit 2014-2019
3.2.2 Boston Scientific Corporation (US) Implantable Cardioverter-Defibrillators (ICD) Business Distribution by Region
3.2.3 Interview Record
3.2.4 Boston Scientific Corporation (US) Implantable Cardioverter-Defibrillators (ICD) Business Overview
3.2.5 Boston Scientific Corporation (US) Implantable Cardioverter-Defibrillators (ICD) Product Specification
3.3 BIOTRONIK SE & Co. KG (Germany) Implantable Cardioverter-Defibrillators (ICD) Business Introduction
3.3.1 BIOTRONIK SE & Co. KG (Germany) Implantable Cardioverter-Defibrillators (ICD) Shipments, Price, Revenue and Gross profit 2014-2019
3.3.2 BIOTRONIK SE & Co. KG (Germany) Implantable Cardioverter-Defibrillators (ICD) Business Distribution by Region
3.3.3 Interview Record
3.3.4 BIOTRONIK SE & Co. KG (Germany) Implantable Cardioverter-Defibrillators (ICD) Business Overview
3.3.5 BIOTRONIK SE & Co. KG (Germany) Implantable Cardioverter-Defibrillators (ICD) Product Specification
3.4 Medtronic PLC (Ireland) Implantable Cardioverter-Defibrillators (ICD) Business Introduction
3.5 St. Jude Medical, Inc. (US) Implantable Cardioverter-Defibrillators (ICD) Business Introduction
3.6 Koninklijke Philips N.V. (Netherlands) Implantable Cardioverter-Defibrillators (ICD) Business Introduction
………………. Request free sample to get a complete Table of Content
About us
BusinessindustryReports.com is digital database of comprehensive market reports for global industries. As a market research company, we take pride in equipping our clients with insights and data that holds the power to truly make a difference to their business. Our mission is singular and well-defined – we want to help our clients envisage their business environment so that they are able to make informed, strategic and therefore successful decisions for themselves.
Media Contact
Business Industry Reports
Pune – India
sales@businessindustryreports.com
+19376349940
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Implantable Cardioverter-Defibrillators (ICD) Market Overview Emerging Trends and Competitive Landscape 2020-2025| ZOLL, Boston, BIOTRONIK, Medtronic, St. Jude Medical, Koninklijke Philips here
News-ID: 2092537 • Views: …
More Releases from Business Industry Reports
Tetracaine Market Exhibits a Lucrative Growth Potential during 2021-2025 | Endo …
BusinessIndustryReports has recently broadcasted a new study to its broad research portfolio, which is titled as “Global Tetracaine Market” Research Report 2021 provides an in-depth analysis of the Tetracaine with the forecast of market size and growth. The analysis includes addressable market, market by volume, market share by business type and by segment (external and in-house). The research study examines the Tetracaine on the basis of a number of criteria,…
Cyber Warfare Market Evenly Poised To Reach A Market Value of US$ By Share, Size …
Overview of Global Cyber Warfare Market:
This report provides in-depth study of “Global Cyber Warfare Market 2021” using SWOT analysis i.e. Strength, Weakness, Opportunities, and Threat to the organization. The Cyber Warfare Market report also provides an in-depth survey of key players in the market organization.
According to the market research study, the Cyber Warfare is virtual conflict between state, organization, or country by the use of computer technology to disrupt activities…
Covid-19 Impact on Cranio Maxillofacial Implant Market 2021-2025: Business Growt …
Overview of Global Cranio Maxillofacial Implant Market:
This report provides in-depth study of “Global Cranio Maxillofacial Implant Market 2021” using SWOT analysis i.e. Strength, Weakness, Opportunities, and Threat to the organization. The Cranio Maxillofacial Implant Market report also provides an in-depth survey of key players in the market organization.
According to the market research study, Craniomaxillofacial Implants are medical implants used in surgeries of maxillofacial region such as, head, face, neck, oral,…
Beginning of the bloom: The Rise of the Biohacking Market 2021-2025 | Global Key …
Global Biohacking Market Synopsis:
The report covers a forecast and an analysis of the Biohacking Market on a global and regional level. The study provides historical data for 2015, 2016, 2017 and 2018 along with a forecast from 2020 to 2025 based on revenue (USD Million) and volume (Kilotons). The study includes drivers and restraints of the Biohacking Market along with the impact they have on the demand over the forecast…
More Releases for ICD
International Classification of Diseases (ICD) -10 Market Expecting Worldwide Gr …
International Classification of Diseases (ICD) -10 is a new system, launched in October 2015 by the World Health Organization (WHO). It classifies and monitors diseases, their symptoms, and track causes of injury and abnormal findings. ICD-10 uses codes to classify the diseases. These codes are used to provide better information of diseases thus helping in improving the quality of patient care. For instance, data captured by ICD-10 can help to…
U.S. Dominates International Classification of Diseases (ICD) 10 Market Worldwid …
International Classification of Diseases (ICD) -10 is a new system, launched in October 2015 by the World Health Organization (WHO). It classifies and monitors diseases, their symptoms, and track causes of injury and abnormal findings. ICD-10 uses codes to classify the diseases. These codes are used to provide better information of diseases thus helping in improving the quality of patient care. For instance, data captured by ICD-10 can help to…
ICD Code Converter Now Available
Clearwater, FL- EON Systems, Inc., the provider of The Digital Office™, a complete software suite for healthcare providers, is excited to announce the launch of its ICD Converter App. The company’s new product, which launched on October 31st, 2014, is available on all Android®, iPad® and iPhone® products.
EON’s ICD Converter app features both ICD-9 to ICD-10 conversion and ICD-10 to ICD-9 conversion. In addition…
Career Step Releases Its New ICD-10 FastTrack Course
PROVO, Utah—September 20, 2013— Career Step, an online school offering career-focused education, is pleased to announce the release of its new ICD-10 FastTrack course, which is designed to prepare ICD-9 trained and experienced medical coders for the October 1, 2014 transition to the ICD-10 code set. This streamlined program was developed in collaboration with renowned industry experts Ann Zeisset, RHIT, CCS, CCS-P, and Gail Smith, MA, RHIA, CCS-P, as well…
Career Step Launches ICD-10-CM/ICD-10-PCS Code Set Training at HIMSS13
PROVO, Utah—March 4, 2013— Career Step, an online education company, is pleased to announce the launch of its ICD-10-CM and ICD-10-PCS code set training at the HIMSS13 Annual Conference & Exhibit. The courses are available through Career Step’s ICD-10 education offering, The ICD-10 Solution, developed in partnership with YES HIM Consulting, Inc., a firm specializing in ICD-10 preparation since 2009.
“As healthcare providers move through their ICD-10 transition plans, ICD-10 code…
Avior Computnig Releases ICD-10 Knowledge Module
Avior Computing Corporation, a leader in automated risk and compliance management, announced today the immediate availability of an ICD-10 Knowledge Module for the firm’s BenchMark compliance management solutions.
The ICD-10 Knowledge Module provides all the content for the Avior BenchMark v6 platform, also released today, to streamline management of the complex interactions between health plans and healthcare providers and their trading partners.
Avior’s ICD-10 Knowledge Module is currently in production use…
